Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-27

FDA Approved: ESZOPICLONE — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for eszopiclone, enabling the approval of a generic version manufactured by Bionpharma Inc. for the treatment of ins…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eszopiclone (eszopiclone)

Snippet

SUPPL AP for ESZOPICLONE (ESZOPICLONE)